BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3022067)

  • 21. Molecularly imprinted polymer for selective determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol carboxylic acid using LC-MS/MS in urine and oral fluid.
    Lendoiro E; de Castro A; Fernández-Vega H; Cela-Pérez MC; López-Vilariño JM; González-Rodríguez MV; Cruz A; López-Rivadulla M
    Anal Bioanal Chem; 2014 Jun; 406(15):3589-97. PubMed ID: 24429976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemp oil ingestion causes positive urine tests for delta 9-tetrahydrocannabinol carboxylic acid.
    Costantino A; Schwartz RH; Kaplan P
    J Anal Toxicol; 1997 Oct; 21(6):482-5. PubMed ID: 9323529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of past and recurrent marijuana use by a modified GC/MS procedure.
    Joern WA
    J Anal Toxicol; 1987; 11(2):49-52. PubMed ID: 3033397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using thin-layer chromatography].
    Nováková E
    Soud Lek; 1997 Feb; 42(1):5-8. PubMed ID: 9221514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gas chromatographic-mass spectrometric quantitation of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid after derivatization by direct extractive alkylation.
    Lisi AM; Kazlauskas R; Trout GJ
    J Chromatogr; 1993 Aug; 617(2):265-70. PubMed ID: 8408392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypochlorite adulteration of urine causing decreased concentration of delta 9-THC-COOH by GC/MS.
    Baiker C; Serrano L; Lindner B
    J Anal Toxicol; 1994; 18(2):101-3. PubMed ID: 8207929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. IV. A comparison of five methods.
    Jones AB; ElSohly HN; Arafat ES; ElSohly MA
    J Anal Toxicol; 1984; 8(6):249-51. PubMed ID: 6097765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of reduced solvent volume solid-phase extraction cartridges with analysis by gas chromatography-mass spectrometry for determination of 11-nor-9-carboxy-delta 9-THC in urine.
    O'Dell L; Rymut K; Chaney G; Darpino T; Telepchak M
    J Anal Toxicol; 1997 Oct; 21(6):433-7. PubMed ID: 9323522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice].
    Hanke M; Megges G
    Z Rechtsmed; 1983; 90(2):105-8. PubMed ID: 6312709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography.
    Whiting JD; Manders WW
    J Anal Toxicol; 1982; 6(1):49-52. PubMed ID: 6281576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full spectral GC/MS identification of delta 9-carboxy-tetrahydrocannabinol in urine with the Finnigan ITS40.
    Wimbish GH; Johnson KG
    J Anal Toxicol; 1990; 14(5):292-5. PubMed ID: 2175819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column.
    Crockett DK; Nelson G; Dimson P; Urry FM
    J Anal Toxicol; 2000; 24(4):245-9. PubMed ID: 10872570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of measurement uncertainty for the quantification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and its glucuronide in urine using liquid chromatography-tandem mass spectrometry.
    Kim JY; Kwon W; Kim HS; Suh S; In MK
    J Anal Toxicol; 2014 Apr; 38(3):164-70. PubMed ID: 24519562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and certification of standard reference material 1507: 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in freeze-dried urine.
    Craft NE; Byrd GD; Hilpert LR
    Anal Chem; 1989 Mar; 61(6):540-4. PubMed ID: 2543236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction.
    Parry RC; Nolan L; Shirey RE; Wachob GD; Gisch DJ
    J Anal Toxicol; 1990; 14(1):39-44. PubMed ID: 2156110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A semi-automated extraction and spotting system for drug analysis by TLC. I. Procedure for analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine.
    Vinson JA; Lopatofsky DJ
    J Anal Toxicol; 1985; 9(1):6-9. PubMed ID: 2984464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thin-layer chromatographic-mass spectrometric identification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid.
    Nakamura GR; Stall WJ; Folen VA; Masters RG
    J Chromatogr; 1983 Jul; 264(2):336-8. PubMed ID: 6309876
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel automated extraction method for quantitative analysis of urinary 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH).
    Fu S; Lewis J
    J Anal Toxicol; 2008 May; 32(4):292-7. PubMed ID: 18430296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
    Nakahara Y; Sekine H; Cook CE
    J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
    Baker TS; Harry JV; Russell JW; Myers RL
    J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.